Therapeutic development for genetically derived cardiomyopathies using patient-derived ipscs
Collaborative research to develop novel therapies for genetically derived cardiomyopathies using patient-derived iPSCs. The work focuses on personalized treatment approaches for dilated cardiomyopathy (DCM) with proven genetic defects, leveraging clinical data and genetic information to address the lack of targeted therapies for inheritable DCM.
Overview
This collaborative research initiative aims to develop novel therapeutic treatments for genetically derived cardiomyopathies, specifically dilated cardiomyopathy (DCM), using induced pluripotent stem cells (iPSCs) derived from patients. By leveraging detailed clinical data and genetic information, the project seeks to create personalized therapeutic approaches, addressing the current gap in targeted treatments for inheritable DCM.
Technical specifications
- iPSC Technology: Utilizes patient-derived iPSCs to study disease mechanisms and identify therapeutic targets.
- Genetic Focus: Targets genetic defects such as LMNA, RBM20, FLNC, and PLN, which are implicated in DCM.
- Comprehensive Data Utilization: Integrates extensive clinical data including medical history, genetic tests, and cardiac imaging to inform therapy development.
Technology readiness level
The initiative is currently at Technology Readiness Level 4, indicating that the research has moved beyond the basic principles and laboratory validation, but still requires further development and collaboration for clinical implementation.
About University of Amsterdam
The University of Amsterdam is a comprehensive public research university with a large international community and broad disciplinary breadth. Industry connects through a major research and technology park that co-locates university labs with startups and corporate R&D, with access to advanced computing and data infrastructure. Integration with the city’s academic medical center enables clinical research, patient access, and pathways for translational validation. Research is supported by competitive national and European funding, including the Dutch Research Council and EU programs. A dedicated knowledge transfer office streamlines IP, contracting, and startup formation, supported by on-campus incubators and venture studios for growth.
delivered to your inbox.